Recombinant Human MYT1 Protein, His-tagged

• Cat.No.: MYT1-3003H
• Product Overview: Recombinant Human MYT1 Protein(134-522 aa), fused with His tag, was expressed in E.coli.

Specification

• Source: E.coli
• Species: Human
• Tag: His
• Form: The purified protein was Lyophilized from sterile PBS (58mM Na2HPO4,17mM NaH2PO4, 68mM NaCl, pH7.4). 5 % trehalose and 5 % mannitol are added as protectant before lyophilization. The elution buffer contain 300mM imidazole.
• Protein Length: 134-522 aa
• Purity: 90%, by SDS-PAGE with Coomassie Brilliant Blue staining.
• Storage: Short-term storage: Store at 2-8°C for (1-2 weeks).
  Long-term storage: Aliquot and store at -20°C to -80°C for up to 3 months, buffer containing 50% glycerol is recommended for reconstitution. Avoid repeat freeze-thaw cycles.
• Reconstitution: Reconstitute at 0.25 µg/μl in 200 μl sterile water for short-term storage.
  Reconstitution with 200 μl 50% glycerol solution is recommended for longer term storage.

Gene Information

• Gene Name: MYT1 myelin transcription factor 1 [ Homo sapiens ]
• Official Symbol: MYT1
• Synonyms: MYT1; myelin transcription factor 1; PLPB1; MTF1; MYTI; myelin transcription factor I; proteolipid protein binding protein; proteolipid protein-binding protein; C20orf36
• Gene ID: 4661
• mRNA Refseq: NM_004535
• Protein Refseq: NP_004526
• MIM: 600379
• UniProt ID: Q01538

Reviews

06/02/2021

MYT1 is highly expressed, which can effectively synthesize a large number of target proteins in host cells.

10/05/2020

MYT1 is highly pure and not adulterated with other proteins or impurities.

06/24/2020

Laboratory personnel reported that the protein was easy to handle, able to meet the needs of experiments, and had a good price-performance ratio.

Q&As

What is the association between MYT1 recombinant protein and tumors?

Studies have shown that MYT1 recombinant protein may be involved in the occurrence and progression of tumors, especially in neurological tumors and breast cancer.

What are the treatments for MYT1 recombinant protein?

The current treatments for MYT1 recombinant protein mainly include gene therapy, protein replacement therapy, and drug therapy for cell cycle and DNA repair processes.

How to detect the level of MYT1 recombinant protein?

The level of MYT1 recombinant protein can be detected by gene sequencing and protein detection methods.

What diseases is MYT1 recombinant protein associated with?

MYT1 recombinant protein is associated with some tumors, neurological diseases, and autoimmune diseases.

If the level of MYT1 recombinant protein is abnormal, what should I do?

If the level of MYT1 recombinant protein is abnormal, the treatment may include the use of drugs or other special treatments, depending on the condition and the doctor's recommendation.

How about the association between MYT1 recombinant protein and other systemic diseases?

Studies have shown that MYT1 recombinant protein may be associated with cardiovascular disease, liver disease, and lung disease.